Publications

[2020-2029] Total Impact Factor Score (JCR 2022) : 306.335 (First & Corresponding) 

22. Jeha Jeon, Young Cha, Yean-Ju Hong, In-Hee Lee, Heejin Jang, Sanghyeok Ko, Serhiy Naumenko, Minseon Kim, Hannah Ryu, Zenith Shrestha, Nayeon Lee, Tae-Yoon Park, HoeWon Park, Seo Hyun Kim, Ki-Jun Yoon, Bin Song, Jeffrey Schweitzer, Todd M. Herrington, Sek Won Kong, Bob S. Carter, Pierre Leblanc, Kwang-Soo Kim. Pre-clinical safety and efficacy of human induced pluripotent stem cell-derived products for autologous cell therapy in Parkinson’s disease. Cell Stem Cell Vol. 32, Issue 3, p343-360 (2025.03.06) Impact factor = 19.8

21. Tae-Yoon Park, Jeha Jeon, Young Cha, Kwang-Soo Kim. Past, Present, and Future of Cell Replacement Therapy for Parkinson’s Disease: A Novel Emphasis on Host Immune Responses. Cell Research, Vol. 34, No. 7, p479-492 (2024.05.22) Impact factor = 44.1

20. Young Cha, Tae-Yoon Park, Pierre Leblanc, Kwang-Soo Kim. Current status and future perspectives on stem cell-based therapies for Parkinson’s disease. Journal of Movement Disorders, Vol. 16, No. 1, p22-41 (2023.1.12) Impact factor = 2.5

19. Tae-Yoon Park*, Jeha Jeon*, Nayeon Lee, Jisun Kim, Bin Song, Jung-Ho Kim, Sang-Kyou Lee, Dongxin Liu, Young Cha, Minseon Kim, Pierre Leblanc, Todd M. Herrington, Bob S. Carter, Jeffrey S. Schweitzer, Kwang-Soo Kim. Co-transplantation of autologous Treg cells in a cell therapy for Parkinson’s disease. Nature, Vol. 619, Issue 7970, p606-615 (* equal contribution) (2023.07.12) Impact factor = 64.8

* Research Highlighted as News and views in Nature 619, p470-472, 2023.

* Research Highlighted as Review in Signal Transduct Target Ther. 8, p430, 2023; J Cereb Blood Flow Metab 44, p1246-1249, 2024.

* Featured in the News: ScienceDaily, GEN, News Azi, Mass General Brigham, etc.

18. Bo-Young Shin, Su-Hyeon Lee, Yuna Kim, Jaekyeung An, Tae-Yoon Park, Sang-Kyou Lee. Interactomic inhibition of Eomes in the nucleus alleviates EAE via blocking the conversion of Th17 cells into non-classic Th1 cells. Immunological Medicine, Vol. 45, No. 2, p119-127 (2022.2.7) Impact factor = 2.7

17. Jeffrey S. Schweitzer*, Bin Song*, Todd M. Herrington*, Tae-Yoon Park*, Nayeon Lee*, Sanghyeok Ko, Jeha Jeon, Young Cha, Kyungsang Kim, Quanzheng Li, Claire Henchcliffe, Michael Kaplitt, Carolyn Neff, Otto Rapalino, Hyemyung Seo, In-Hee Lee, Jisun Kim, Taewoo Kim, Greg A. Petsko, Jerome Ritz, Bruce M. Cohen, Sek Won Kong, Pierre Leblanc, Bob S. Carter, Kwang-Soo Kim. Personalized iPSC-derived dopamine progenitor cells for Parkinson’s disease. New England Journal of Medicine, Vol. 382, No. 20, p1926-1932 (* equal contribution) (2020.05.14) Impact factor = 158.5

* Research Highlighted as In Translation in Cell Stem Cell 27, p8-10, 2020.

* Featured in the News: The New York Times, STAT News, ScienceDaily, Reuters, Mass General Brigham, etc.

[2010-2019]

16.  Tae-Yoon Park, Yongwoo Jang, Woori Kim, Joon Shin, Hui Ting Toh, Chun-Hyung Kim, Ho Sup Yoon, Pierre Leblanc, Kwang-Soo Kim. Chloroquine modulates inflammatory autoimmune responses through Nurr1 in autoimmune diseases. Scientific Reports, Vol. 9, No. 1, 15559 (2019.10.29) Impact factor = 4.997

15.  Jae-Seung Moon, Chin Hee Mun, Jung-Ho Kim, Jen-Young Cho, Sung-Dong Park, Tae-Yoon Park, Jin-Su Shin, Chun-Chang Ho, Yong-Beom Park, Sankar Ghosh, Alfred LM Bothwell, Sang-Won Lee, Sang-Kyou Lee. Intranuclear delivery of the transcription modulation domain of Tbet-improved lupus nephritis in (NZB/NZW) F1 lupus-prone mice. Kidney International, Vol. 93, No. 5, p1118-1130 (2018.5)

14.  Sung-Dong Park, So Yeong Cheon, Tae-Yoon Park, Bo-Young Shin, Hyunju Oh, Sankar Ghosh, Bon-Nyeo Koo, Sang-Kyou Lee. Intranuclear interactomic inhibition of NF-κB suppresses LPS-induced severe sepsis. Biochemical and Biophysical Research Communication, Vol. 464, No. 3, p711-717 (2015.8.28)

13.  Tae-Yoon Park, Sung-Dong Park, Jen-Young Cho, Jae-Seung Moon, Na-Yeon Kim, Kyungsoo Park, Rho Hyun Seong, Sang-Won Lee, Tomohiro Morio, Alfred L. M. Bothwell and Sang-Kyou Lee. RORγt-specific transcriptional interactomic inhibition suppresses autoimmunity associated with TH17 cells. Proc Natl Acad Sci U S A, Vol. 111, No. 52, p18673-18678 (2014.12.30) Impact factor = 12.779

12.  Dashlkhumbe Byamba, Do Young Kim, Dae-Suk Kim, Tae-Gyun Kim, Hyunjoong Jee, Sung Hee Kim, Tae-Yoon Park, Sang-Hwa Yang, Sang-Kyou Lee and Min-Geol Lee. Skin-penetrating methotrexate alleviates imiquimod-induced psoriasiform dermatitis via decreasing IL-17-producing gamma delta T cells. Experimental Dermatology, Vol. 23, Issue. 7, p492-496 (2014.7)

11.  Tae-Yoon Park, Min-Jung Shin, Sung-Dong Park, and Sang-Kyou Lee. Alleviation of abnormal synaptic neurotransmitter release by cell-permeable form of the truncated SNAP-25 upon transcutaneous delivery. Neuroscience Letters, Vol. 543, p52-57 (2013.5.24) Impact factor = 3.197

10.  Tae-Yoon Park, Seung-Hyung Kim, Yoon-Chul Shin, Nae-Hyun Lee, Christina Rae-Kyung Lee, Jae-Hyuck Shin, Laurie Glimcher, Inhee Mook-Jung, Eunji Cheong, Won-Ki Kim, Fumiko Honda, Tomohiro Morio, Jong-Soon Lim, and Sang-Kyou Lee. Amelioration of neurodegenerative diseases by cell death-induced cytoplasmic delivery of humanin. Journal of Controlled Release, Vol. 166, Issue 3, p307-315 (2013.3.28) Impact factor = 11.467

9.  Jingyu Bae, Jihye Koo, Soochan Kim, Tae-Yoon Park, and Mi-Yeon Kim. Ginsenoside Rp1 Exerts Anti-inflammatory Effects via Activation of Dendritic Cells and Regulatory T Cells. Journal of Ginseng Research, Vol. 36, No. 4, 375-382 (2012.10)

8.  Endale M, Lee WM, Kamruzzaman SM, Kim SD, Park JY, Park MH, Park TY, Park HJ, Cho JY, Rhee MH. Ginsenoside-Rp1 inhibits platelet activation and thrombus formation via impaired GPVI signaling pathway tyrosine phosphorylation and MAPK activation. British Journal of Pharmacology, Vol. 167, Issue. 1, p109-127 (2012.9)

7.  Je-Min Choi, Jung-Ho Sohn, Tae-Yoon Park, Jung-Won Park, Sang-Kyou Lee. Cell permeable NFAT inhibitory peptide Sim-2-VIVIT inhibits T-cell activation and alleviates allergic airway inflammation and hyper-responsiveness. Immunology letters, Vol. 143, Issue. 2, p170-176 (2012.4.30)

[2006-2009]

6.  Ashok Kumar, Madhu Kumar, Tae-Yoon Park, Myung-Hwan Park, Tadashi Takemoto, Tokio Terado, Masaru Kitano, Hiroshi Kimura. Molecular mechanisms of ginsenoside Rp1-mediated growth arrest and apoptosis. International Journal of Molecular Medicine, Vol. 24, No. 3, p381-386 (2009.9)

5.  Byung Hun Kim, Yong Gyu Lee, Tae Yoon Park, Ho Bang Kim, Man Hee Rhee, Jae Youl Cho. Ginsenoside Rp1, a Ginsenoside Derivative, Blocks Lipopolysaccharide-Induced Interleukin-1 beta Production via Suppression of the NF-kappa B Pathway. Planta Medica, Vol. 75, Issue. 4, p321-326 (2009.3)

4.  Tae-Yoon Park and Jae-Youl Cho. Inhibitory Effect of Ginsenoside-Rp1, a Novel Ginsenoside Derivative, on the Functional Activation of Macrophage-like Cells. Biomolecules & Therapeutics, Vol. 16, No. 4, p370-376 (2008.12.31) Impact factor = 4.231

3.  Tae Yoon Park, Myung Hwan Park, Won Cheol Shin, Man Hee Rhee, Dong Wan Seo, Jae Youl Cho, and Hwan Mook Kim. Anti-metastatic Potential of Ginsenoside Rp1, a Novel Ginsenoside Derivative. Biological & Pharmaceutical Bulletin, Vol. 31, No. 9, p1802-1805 (2008.9) Impact factor = 2.264

2.  Jun-Ho Lee, Sun-Hye Choi, Byung-Hwan Lee, In-Soo Yoon, Tae-Jun Shin, Mi Kyung Pyo, Sang-Mok Lee, Hyewhon Rhim, Myung Hwan Park, Tae Yoon Park, and Seung-Yeol Nah. Modifications of Aliphatic Side Chain of 20(S)-Ginsenoside Rg3 Cause an Enhancement or Loss of Brain Na+ Channel Current Inhibitions. Biological and Pharmaceutical Bulletin, Vol. 31, No. 3, p480-486 (2008.3)

1. Ashok Kumar, Madhu Kumar, Meenakshi Panwar, Ravindra M. Samarth, Tae-Yoon Park, Myung-Hwan Park and Hiroshi Kimura. Evaluation of chemopreventive action of Ginsenoside Rp1. BioFactors, Vol. 26 p29-43 (2006)